Olaparib in recurrent IDH-mutant high-grade glioma (OLAGLI).

2007Background: There is a need to develop new treatments in IDH-mutant high-grade gliomas recurring after radiotherapy and chemotherapy. Based on preclinical studies showing that IDH-mutant tumors...